Journal Watch

  • Glycated Albumin vs. HbA1c Predicts Mortality in PD Patients with Diabetes

    In patients on hemodialysis, glycated albumin (GA) reflects glycemic control and predicts all-cause mortality. A new retrospective, longitudinal observational study looked at GA in PD. Among 44 PD patients with diabetes matched to 88 HD patients with diabetes followed for 3 years, GA was a more precise way to measure glycemic control than hemoglobin A1c.

    Read the abstract » | (added 2019-09-11)

  • BMI Alters Sodium Balance in PD

    In a review of 439 PD patients, those with more urine volume, protein nitrogen appearance rate, fewer comorbidities, and higher BMI had greater sodium losses.

    Read the abstract » | (added 2019-09-11)

  • A Patient on Home HD for 45 Years

    A 62-year old Mississippi woman, one of the first home HD patients of Dr. John D. Bower, is reported to have been on home HD for 45 years now, a record.

    Read the abstract » | (added 2019-09-11)

  • RCT: Which Works Best, Straight or Coiled PD Catheters?

    A metaanalysis recently found that straight catheters were better, and an RCT of 308 CAPD patients randomly assigned to receive a straight (n=153) or coiled (n=155) catheter corroborates that finding. After a mean follow-up of 21 months, straight PD catheters caused almost 9 times less dysfunction or drainage failure (0.7% vs. 5.8%) with less pain than coiled catheters. Both catheters had a similar risk of peritonitis.

    Read the abstract » | (added 2019-09-11)

  • Some PD PETs Are Better Than Others

    There are three ways to do a peritoneal equilibrium test (PET) to measure how well someone’s peritoneum is able to transport water and wastes. Compared to a traditional PET, a modified PET had good agreement in 21 patients—but the so-called mini-PET did not.

    Read the abstract » | (added 2019-08-14)

  • PD: Better Quality of Life than In-Center HD for 2 Years

    Among 989 patients starting PD or in-center HD, health-related quality of life (HRQOL) was measured at 3, 12, and 24 months after dialysis start. PD patients scored higher all along on several key dimensions than HD patients—and this effect lasted up to 2 years. Both PD and HD patients had about the same amount of decline in HRQOL over 2 years.

    Read the abstract » | (added 2019-08-14)

  • Payment Policy is Driving Increases in U.S. Home Dialysis

    Follow the money. Analysis of 523,526 patients starting dialysis in the U.S. between 2005 and 2013 found increases in home dialysis use in all groups, and a decline in racial/ethnic differences in home dialysis. However, over time, white patients had an increase in mortality compared to minority patients, while transplant rates remained lower in minority patients.

    Read the abstract » | (added 2019-08-14)

  • Challenges in Assessing Survival of In-center vs. Home HD

    It’s treatment time that matters, not location—of course—suggests a new thorough review of the survival data. And, while it is challenging to prove a survival benefit when all home HD is so often conflated (short daily vs. nocturnal, for example), quality of life is demonstrably better—and matters more to patients.

    Read the abstract » | (added 2019-08-14)

  • Remote PD Monitoring Reduced Hospitalizations

    A study of people starting automated PD matched patients who did and did not receive remote patient monitoring (RPM), with 63 patients in each group. Those who received RPM had significantly fewer hospital stays and days.

    Read the abstract » | (added 2019-08-14)

  • High Fiber Diet May Save Lives on PD

    A study of 881 PD patients followed for up to 12 years found that participants who ate more fiber tended to be younger, male, and have more residual kidney function. In those who did not have diabetes, each 1 gram increase in daily fiber intake independently predicted improved survival by 13%.

    Read the abstract » | (added 2019-08-14)